Stockholm - Free Realtime Quote SEK
Active Biotech AB (publ) (ACTI.ST)
As of 1:06 PM GMT+2. Market Open.
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in SEK.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Ms. Helen Tuvesson Ph.D. | President & CEO | 4.04M | -- | 1962 |
| Mr. Hans Kolam | Chief Financial Officer | -- | -- | 1951 |
| Dr. Erik Vahtola | Chief Medical Officer | -- | -- | 1976 |
Active Biotech AB (publ)
- Sector:?
- Healthcare
- Industry:? Biotechnology
- Full Time Employees:?
- 8
Description
Active Biotech AB (publ), a biotechnology company, engages in the research, development, and production of pharmaceutical products in Sweden. It is developing Tasquinimod, a small molecule immunomodulator, which is in Phase Ib/IIa clinical trial to treat multiple myeloma; Laquinimod, an immunomodulator that has completed phase I clinical trial for the treatment of inflammatory eye disorders, including uveitis; and Naptumomab, an immunotherapy, which is in phase Ib/II study to treat patients with solid tumors. The company was incorporated in 1983 and is headquartered in Lund, Sweden.
Corporate Governance
Active Biotech AB (publ)’s ISS Governance QualityScore as of October 1, 2024 is 10. The pillar scores are Audit: 10; Board: 10; Shareholder Rights: 1; Compensation: 10.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
November 7, 2024 at 10:59 AM UTC
Active Biotech AB (publ) Earnings Date
Recent Events
Recent Events Information Not Available
Related Tickers
LPGO.ST Lipigon Pharmaceuticals AB (publ)
0.1820
-1.09%
WNT.ST WntResearch AB
0.8320
-7.56%
NICA.ST Nanologica AB (publ)
2.3000
-2.95%
DIABIO.ST Diagonal Bio AB (publ)
0.0370
-4.64%
XBRANE.ST Xbrane Biopharma AB (publ)
0.2110
+17.22%
FLUI.ST Fluicell AB (publ)
0.0748
+1.63%
XSPRAY.ST Xspray Pharma AB (publ)
62.10
+2.14%
ONCO.ST Oncopeptides AB (publ)
2.0800
-0.24%
EXPRS2.ST ExpreS2ion Biotech Holding AB (publ)
0.8730
-2.57%
SPRO Spero Therapeutics, Inc.
1.2800
-0.39%